title: Systemic alteration of cell-surface and secreted glycoprotein expression in malignant breast cancer cell lines.
abstract: Breast cancer cell lines express fewer transmembrane and secreted glycoproteins than nonmalignant ones. The objective of these experiments was to characterize the changes in the expression of several hundred glycoproteins quantitatively. Secreted and cell-surface glycoproteins were isolated using a glycoprotein capture protocol and then identified by tandem mass spectrometry. Glycoproteins expressed by a group of cell lines originating from malignant tumors of the breast were compared with those expressed by a nonmalignant set. The average number of spectral counts (proportional to relative protein abundance) and the total number of glycopeptides in the malignant samples were reduced to about two-thirds of the level in the nonmalignant samples. Most glycoproteins were expressed at a different level in the malignant samples, with nearly as many increasing as decreasing. The glycoproteins with reduced expression accounted for a larger change in spectral counts, and hence for the net loss of spectral counts in the malignant lines. Similar results were found when the glycoproteins were studied via identified glycosylation sites only, or through identified sites together with non-glycopeptides. The overall reduction is largely due to the loss of integrins, laminins and other proteins that form or interact with the basement membrane.
authors.affiliation: Department of Chemistry and Biochemistry, San Francisco State University, 1600 Holloway Avenue, San Francisco, CA 94132, USA.
authors.forename: Leslie C
authors.initials: LC
authors.lastname: Timpe
authors.forename: Roger
authors.initials: R
authors.lastname: Yen
authors.forename: Nicole V
authors.initials: NV
authors.lastname: Haste
authors.forename: Christina
authors.initials: C
authors.lastname: Litsakos-Cheung
authors.forename: Ten-Yang
authors.initials: TY
authors.lastname: Yen
authors.forename: Bruce A
authors.initials: BA
authors.lastname: Macher
mesh_terms: D000595:Amino Acid Sequence; D001943:Breast Neoplasms; D045744:Cell Line, Tumor; D016384:Consensus Sequence; D005260:Female; D018628:Gene Dosage; D006023:Glycoproteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D006031:Glycosylation; D006801:Humans; D008565:Membrane Proteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D011499:Protein Processing, Post-Translational; D020543:Proteome / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D014158:Transcription, Genetic
chemical_list: D006023:Glycoproteins; D008565:Membrane Proteins; D020543:Proteome; D012333:RNA, Messenger
keywords: breast cancer; glycoproteins; glycosylation sites; mass spectrometry; proteomics
references.citation: Biochim Biophys Acta. 2009 Apr;1788(4):872-91
references.pmid: 19059202
references.citation: Br J Cancer. 1999 Dec;81(8):1328-34
references.pmid: 10604729
references.citation: Cold Spring Harb Perspect Biol. 2011 Dec 01;3(12):
references.pmid: 21917992
references.citation: Nat Biotechnol. 2009 Apr;27(4):378-86
references.pmid: 19349973
references.citation: Cancer Cell. 2009 May 5;15(5):402-15
references.pmid: 19411069
references.citation: J Proteome Res. 2010 Oct 1;9(10):5311-24
references.pmid: 20681588
references.citation: Cell. 2010 May 28;141(5):897-907
references.pmid: 20510933
references.citation: Mol Cell Proteomics. 2013 Jan;12(1):158-71
references.pmid: 23090970
references.citation: Mol Cell Proteomics. 2009 Feb;8(2):287-301
references.pmid: 18923192
references.citation: Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):2724-9
references.pmid: 22003129
references.citation: J Proteome Res. 2012 Feb 3;11(2):656-67
references.pmid: 22106898
references.citation: Glycobiology. 2012 Nov;22(11):1440-52
references.pmid: 22798492
references.citation: J Biomed Biotechnol. 2010;2010:840518
references.pmid: 19911078
references.citation: Nat Biotechnol. 2003 Jun;21(6):660-6
references.pmid: 12754519
references.citation: Cell. 2009 Jun 26;137(7):1259-71
references.pmid: 19563758
references.citation: J Proteome Res. 2009 Aug;8(8):4151-60
references.pmid: 19522481
references.citation: Cancer Res. 2012 May 1;72(9):2428-39
references.pmid: 22414580
references.citation: J Proteome Res. 2006 Nov;5(11):2909-18
references.pmid: 17081042
references.citation: J Proteome Res. 2012 Apr 6;11(4):2508-20
references.pmid: 22309216
references.citation: Mol Cell Proteomics. 2005 Oct;4(10):1487-502
references.pmid: 15979981
references.citation: Mol Cell Proteomics. 2007 Nov;6(11):1997-2011
references.pmid: 17656355
references.citation: Mol Cell Proteomics. 2009 Jun;8(6):1436-49
references.pmid: 19321434
references.citation: Glycobiology. 2002 Apr;12(4):43R-56R
references.pmid: 12042244
references.citation: Nat Rev Cancer. 2002 Jun;2(6):442-54
references.pmid: 12189386
references.citation: Cancer Cell. 2006 Dec;10(6):515-27
references.pmid: 17157791
references.citation: PLoS Genet. 2010 Sep 02;6(9):e1001090
references.pmid: 20824076
references.citation: Biochim Biophys Acta. 2012 Dec;1826(2):297-311
references.pmid: 22613680
references.citation: Nat Rev Cancer. 2005 Nov;5(11):845-56
references.pmid: 16239904